Welcome to Bio2Business Ltd: Home of BOS Events; CRO Tracker; News and comment from the R&D Outsourcing Community
"BOS has quickly established itself as one of the most useful conferences for pharmaceutical outsourcing. The central location and focussed agenda makes it a great use of time"
Sharon Grimster, VP Regulatory, Pharmaceutical & Business Operations, Antisoma plc
AMYLGEN present at Bio Spring Europe and AD/PD 2013 meeting
AMYLGEN was present and participated to the Bio Spring Europe partnering meeting held in Barcelona, Spain, March 11 to 13, 2013.
At the same time, AMYLGEN was present at the 11th International Conference...
Read News in full
Access BOS Events presentations past and present in PDF, Audio or Video Format
Access to Data Center content is available to BOS Events attendees (past and present) and CRO Tracker members with full access rights. Please login here or register now to request access.
Bio2Business is pleased to welcome 3 new speakers to our line up ahead of Biotech Outsourcing Strategies cmc 2014, 12th June. Rikke Morkeberg, Director of Drug Development, Alk Abello, will present in the Biologics Track re: "Managing QbD in Outsourced Projects". Rikke will be exploring the challenges of aligning external partner's process with established internal quality process. From Opsona Therapeutics we are pleased to welcome Mary Reilly, VP Pharmaceutical Development and Operations. Mary's talk will cover the development path of OPN-305, Opsona's first in class monoclonal antibody, with a specific focus on regulatory aspects encountered through early development. Opsona recently raised 36 million Euro in series C financing. Finally we are pleased to welcome back Maarten van Geffen, VP CMC, Operations & Quality, Amakem Therapeutics who will talk through a case study in building a robust CMC data package with a view to acquisition. Visit the BOS cmc 2014 website for further details.